Recombinant GFRA3 (Nadecnemab Biosimilar) antibody

Catalog No. ABIN7581424

The Human Monoclonal anti-GFRA3 (Nadecnemab Biosimilar) antibody has been validated for ELISA, FACS, BLI, Func and SPR. It is suitable to detect GFRA3 (Nadecnemab Biosimilar) in samples from Human.

Quick Overview for Recombinant GFRA3 (Nadecnemab Biosimilar) antibody (ABIN7581424)

Target: GFRA3 (Nadecnemab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This GFRA3 (Nadecnemab Biosimilar) antibody is un-conjugated

Application: ELISA, Flow Cytometry (FACS), Bio-Layer Interferometry (BLI), Functional Studies (Func), Surface Plasmon Resonance (SPR)

Product Details anti-GFRA3 (Nadecnemab Biosimilar) Antibody

Expression System: CHO Cells

Purpose: Anti-GFRA3 Reference Antibody (nadecnemab)

Characteristics: Anti-GFRA3 Reference Antibody (nadecnemab) is expressed from CHO. The heavy chain type is huIgG4SP, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.

Purity: >95 %

Isotype: IgG4

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Concentration: 1 mg/mL

Buffer: 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2

Storage: 4 °C,-80 °C

Storage Comment: +4°C,-80°C

Target Details for GFRA3 (Nadecnemab Biosimilar)

Target: GFRA3 (Nadecnemab Biosimilar)

Target Type: Biosimilar

Molecular Weight: 145.5 kDa

UniProt: O60609